Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Alibaba Stock Is a Roaring Tiger Again

By Chris Lau, InvestorPlace Contributor

The worst is finally over for BABA stock as the Chinese government loosens restrictions against the industry.

Mullen Stock Is a Worthwhile Lottery Ticket

By Chris Lau, InvestorPlace Contributor

Mullen is one of the few cheap stocks with potential long-term upside, if this EV and battery developer delivers a product.

7 Growth Stocks to Buy After the Market Crash

By Chris Lau, InvestorPlace Contributor

Great stock deals are approaching after market crashes, rewarding investors willing to wait for better discounts on fast-growing companies.

AMC Stock Is Undervalued Considering These Three Catalysts

By Chris Lau, InvestorPlace Contributor

AMC is ready to grow out of the meme frenzy and trade according to its fundamentals improving strongly from here.

7 Blue-Chip Stocks to Avoid in a Bear Market

By Chris Lau, InvestorPlace Contributor

These stocks do not live up to their blue-chip name, as inflation, higher interest rate, and recessionary risks rise.

Load More